Business Daily from THE HINDU group of publications
Thursday, Jan 29, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
Business Daily from THE HINDU group of publications Thursday, Jan 29, 2009 ePaper | Mobile/PDA Version | Audio | Blogs |
|
|
|
|
|
Industry & Economy
-
Pharmaceuticals Drug prices increased Our Bureau New Delhi, Jan. 28 Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has revised the price of 174 formulation packs and three bulk drugs. Prices of most of the drugs have been revised upward. The drugs whose prices are revised by the regulator include popular medicines such as insulin, pain killer ibuprofen in various combinations, chloroquine and multivitamin suspensions in bottles, according to the information available on the regulator’s Web site. The list includes the prices of the medicines marketed in India by companies such as Pfizer, Win-Medicare, Novartis India and Shreya Life Sciences. Medicines in the list also include four formulations whose prices were fixed for the first time by the regulator. NPPA has also revised the price of three bulk drugs Theophylline, Hydroxy Ethyl Theophyline and Vitamin E Acetate. The fixed and revised notified prices shall become effective within 15 days from the date of notification in the official gazette, the regulator said in a statement. All formulators utilising these drugs in their scheduled formulations are advised to follow the provisions of the Drug Price Control Order, 1995, it added More Stories on : Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2009, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|
